| Lam, Marnix G |
| Recruiting | 3 | 288 | Europe, Canada, US, RoW | RYZ101, Everolimus, Sunitinib, Octreotide, Lanreotide | RayzeBio, Inc., RayzeBio, Inc. | GEP-NET, Gastroenteropancreatic Neuroendocrine Tumor, Gastroenteropancreatic Neuroendocrine Tumor Disease, Neuroendocrine Tumors, Carcinoid, Carcinoid Tumor, Pancreatic NET | 12/25 | 07/28 | | |
STARLIGHT, NCT06563986: FTD-TPI, Bevacizumab, and Radioembolization With 166Ho-microspheres in Refractory Metastatic Colorectal Cancer |
|
|
| Recruiting | 2 | 40 | Europe | Systemic treatment (FTD-TPI and bevacizumab), Radioembolization with 166-Ho microspheres | UMC Utrecht | Metastatic Colorectal Cancer | 01/28 | 06/28 | | |
iHEPAR, NCT05114148: Individualized Dosimetry for Holmium-166-radioembolization in Patients With Unresectable Hepatocellular Carcinoma |
|
|
| Recruiting | 2 | 30 | Europe | Holmium-166 radioembolization | UMC Utrecht, Erasmus Medical Center, Terumo Corporation | Hepatocellular Carcinoma Non-resectable | 11/24 | 11/25 | | |
| Recruiting | 2 | 220 | Europe | radioembolization, Standard of care first-line systemic therapy | UMC Utrecht, Dutch Colorectal Cancer Group | Colorectal Cancer Metastatic | 10/25 | 10/28 | | |
| Recruiting | N/A | 150 | Europe | PSMA-PET/CT | Roderick van den Bergh | Prostate Cancer | 10/25 | 10/25 | | |
| Recruiting | N/A | 50 | Europe | [18F]F-FAPI PET-CT | Erasmus Medical Center, Dutch Cancer Society, Academisch Ziekenhuis Maastricht, Missie Tumor Onbekend, Noordwest Ziekenhuisgroep, Cyclotron Noordwest BV | Cancer of Unknown Primary | 08/26 | 03/27 | | |
| Not yet recruiting | N/A | 60 | Europe | 68Ga-PSMA-PET/CT scan, Online patient reported outcome measure (PROM) questionnaires, Blood sampling | The Netherlands Cancer Institute, Bayer | mCRPC, Male Urogenital Diseases | 07/29 | 07/29 | | |
